Stocks
Bio-Rad Laboratories (BIO) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -84.8% | -160.2% | -24.5% | -83.5% | 18.4% | 1.34% | ||
| Changes by years, y/y, % | -276pp | -75pp | +136pp | -59pp | +102pp | -38.0% | |||
Bio-Rad Laboratories. EBITDA margin, %
Bio-Rad Laboratories. EBITDA margin, changes, pp
Bio-Rad Laboratories (BIO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 22.8% | 73.2% | 18.5% | 16.5% | -114.4% | 1.34% | |
| Changes by years, y/y, % | -67pp | +500pp | -124pp | +143pp | -137pp | |||
| Changes by quarters, q/q, % | +150pp | +50pp | -55pp | -2pp | -131pp | |||
